Hospital
Salina Regional Health Center, INC
Salina Regional Health Center, INC was paid $3.40M by Medicaid between Jan 2018 and Nov 2024, across 136 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoSALINA REGIONAL HEALTH CENTER, INC
SALINA, KS 67401
SALINA, KS 67401
33aNPI1689635138assigned 03/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.40M
24GClaims159,074
24DCodes billed136
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Kansas
Rank by total paid#10 of 48
Median peer was paid$461K
This provider vs. median7.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,786 | $774K | |
| 2019 | 23,862 | $494K | |
| 2020 | 16,609 | $299K | |
| 2021 | 22,545 | $479K | |
| 2022 | 22,676 | $539K | |
| 2023 | 23,851 | $456K | |
| 2024incomplete | 14,745 | $360K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 14,563 | 14,158 | $652K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 13,431 | 12,964 | $579K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 12,419 | 11,801 | $572K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 9.5% | 3,011 | 2,950 | $323K |
| 80053 | Comprehensive metabolic panel | 6.6% | 25,932 | 23,218 | $223K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5.4% | 6,884 | 5,710 | $185K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.2% | 10,224 | 9,715 | $177K |
| 97597 | 3.3% | 1,321 | 664 | $113K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 19,094 | 17,208 | $70K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 3,394 | 3,203 | $50K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 409 | 399 | $37K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 644 | 640 | $37K |
124 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 531 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,770 | $29K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,872 | $28K |
| 83690 | <1% | 3,694 | $23K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,423 | $17K |
| G0378 | Hospital observation service, per hour | <1% | 425 | $17K |
| 87081 | <1% | 2,040 | $16K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 641 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 632 | $12K |
| 0240U | <1% | 123 | $10K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 164 | $10K |
| 87632 | <1% | 183 | $9K | |
| 84703 | <1% | 1,030 | $9K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 93 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 242 | $8K |
| 81003 | <1% | 6,370 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 110 | $7K |
| 84439 | <1% | 788 | $7K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 249 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 692 | $6K |
| 82728 | <1% | 314 | $6K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 490 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 467 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 400 | $5K |
| 80061 | Lipid panel | <1% | 488 | $4K |
| 85027 | <1% | 540 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $4K |
| 84484 | <1% | 397 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 482 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 76 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 74 | $3K |
| 86885 | <1% | 140 | $3K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 64 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 14 | $3K |
| 85610 | <1% | 566 | $3K | |
| 97161 | <1% | 49 | $2K | |
| 87807 | <1% | 125 | $2K | |
| 93976 | <1% | 38 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 217 | $2K |
| 85730 | <1% | 407 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 39 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 55 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 35 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,513 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 243 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,059 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 53 | $1K |
| 87186 | <1% | 126 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 120 | $1K |
| 87634 | <1% | 29 | $1K | |
| 87653 | <1% | 24 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,269 | $973.34 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 28 | $932.84 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 20 | $915.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 15 | $910.00 |
| 87077 | <1% | 126 | $866.33 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 16 | $866.00 |
| 83605 | <1% | 110 | $800.01 | |
| 83615 | <1% | 152 | $774.61 | |
| 36410 | <1% | 90 | $669.31 | |
| 86901 | <1% | 114 | $661.93 | |
| 83735 | <1% | 131 | $627.78 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 34 | $609.57 |
| 73630 | <1% | 49 | $587.55 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $582.65 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 15 | $575.46 |
| 86592 | <1% | 83 | $554.19 | |
| 82962 | <1% | 106 | $532.90 | |
| 85014 | <1% | 318 | $516.40 | |
| 85018 | <1% | 302 | $502.89 | |
| 86900 | <1% | 107 | $498.27 | |
| 74018 | <1% | 44 | $474.72 | |
| 87040 | <1% | 57 | $450.23 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 28 | $449.24 |
| 87210 | <1% | 37 | $425.56 | |
| 76937 | <1% | 43 | $407.14 | |
| 83880 | <1% | 28 | $388.58 | |
| 86140 | <1% | 64 | $364.70 | |
| 84702 | <1% | 34 | $334.92 | |
| 73110 | <1% | 20 | $333.83 | |
| 96376 | <1% | 30 | $327.67 | |
| 92081 | <1% | 12 | $306.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 16 | $303.90 |
| 85379 | <1% | 61 | $302.70 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 88 | $283.67 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 217 | $281.37 |
| 73562 | <1% | 15 | $275.70 | |
| 83721 | <1% | 66 | $252.76 | |
| 82607 | <1% | 38 | $250.83 | |
| 82950 | <1% | 32 | $245.43 | |
| 87070 | <1% | 40 | $245.09 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 178 | $242.55 |
| 72100 | <1% | 13 | $239.08 | |
| 85007 | <1% | 129 | $222.03 | |
| 86850 | <1% | 25 | $221.53 | |
| 74019 | <1% | 32 | $197.61 | |
| 82803 | <1% | 15 | $191.05 | |
| 82746 | <1% | 24 | $174.02 | |
| 85049 | <1% | 15 | $139.88 | |
| 82565 | <1% | 33 | $137.60 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,531 | $117.07 |
| 85652 | <1% | 30 | $113.42 | |
| 83540 | <1% | 26 | $113.17 | |
| 73502 | <1% | 13 | $105.57 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 50 | $98.23 |
| 84550 | <1% | 13 | $81.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 158 | $69.22 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 94 | $68.59 |
| 82947 | <1% | 13 | $64.09 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 19 | $36.93 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 15 | $33.94 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 44 | $32.52 |
| 82077 | <1% | 25 | $31.71 | |
| 81001 | <1% | 12 | $29.40 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $26.33 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 13 | $7.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 13 | $5.47 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 234 | $4.80 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 13 | $2.14 |
| 90461 | 0% | 18 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 59 | $0.00 |
| 90686 | 0% | 31 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTALLON, JOE (VP/CFO)